We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PharmAthene, SIGA Merger to Focus on Biodefense Treatments
PharmAthene, SIGA Merger to Focus on Biodefense Treatments
March 31, 2006
PharmAthene and SIGA Technologies have signed a merger agreement to create a biodefense company that will focus on top priorities of Project BioShield, including treatments for anthrax and smallpox.